Brief: Theradiag Notes Capital Stake Acquisition By Biosynex
Nov 30 (Reuters) - THERADIAG SA ALTHE.PA :
* THERADIAG NOTES THE ACQUISITION OF A STAKE IN ITS CAPITAL
BY
BIOSYNEX
* FOLLOWING ACQUISITIONS ON MARKET AND ITS PARTICIPATION IN
RIGHTS
ISSUE, BIOSYNEX HELD 2,468,932 SHARES, I.E. 18.82% OF
THERADIAG'S SHARE CAPITAL AND 18.89% OF ITS VOTING RIGHTS, AS AT
29 NOVEMBER 2021
Source text for Eikon: ID:nBw6bzztBa
Further company coverage: ALTHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals